Risk of Death and Adverse Effects in Patients on Liothyronine: A Multisource Systematic Review and Meta-analysis
Our findings are reassuring that regulated LT3 use is not associated with the risk of death or serious AEs. More studies are needed to supplement existing data.
Authors
- Colin Mark Dayan (ORCID: https://orcid.org/0000-0002-6557-3462)
- Lakdasa Premawardhana (ORCID: https://orcid.org/0000-0003-0931-3700)
- Suhani Bahl (ORCID: https://orcid.org/0009-0002-3216-896X)
- Mike Stedman (ORCID: https://orcid.org/0000-0002-0491-7823)
- Onyebuchi Okosieme (ORCID: https://orcid.org/0000-0003-2221-992X)
- Peter Nicholas Taylor (ORCID: https://orcid.org/0000-0002-3436-422X)
- Adrian Hugh Heald (ORCID: https://orcid.org/0000-0002-9537-4050)
Institutions
- Manchester Academic Health Science Centre (GB)
- Concord Consortium (US)
- Cwm Taf University Health Board (GB)
- University of Manchester (GB)
- Clinical Research Consortium (US)
- University of Wales Institute Cardiff (SG)
- Cardiff University (GB)
Publication Details
- Journal
- The Journal of Clinical Endocrinology & Metabolism
- Published
- 2025-08-08
- DOI
- https://doi.org/10.1210/clinem/dgaf449
- Citations
- 4
- Primary Topic
- Thyroid Disorders and Treatments
- Type
- article
- Field-Weighted Citation Impact
- 5.18